Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure:

Elodie Gouadon1, Thomas Moore-Morris2, Nicoline W Smit3

  • 1INSERM UMR-S999, LabEx LERMIT, IPSIT Centre Chirurgical Marie Lanelongue, Le Plessis Robinson, Paris, France.

Stem Cells (Dayton, Ohio)
|September 10, 2015
PubMed

Insights

Pluripotent stem cells offer potential for cardiac regeneration, but current therapies face challenges. This review addresses challenges and proposes guidelines for safe and effective clinical translation of stem cell therapies for heart failure.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Stem Cell Biology

Background:

  • Heart failure remains a leading cause of hospitalization and mortality globally.
  • Multipotent stem cell therapies have shown limited patient benefit in cardiac regenerative medicine.
  • Pluripotent stem cells are being investigated as an alternative cell source for cardiac repair.

Purpose of the Study:

  • To review pluripotent stem cells as a source for cardiac regeneration.
  • To identify and discuss challenges associated with pluripotent stem cell therapy for heart conditions.
  • To propose guidelines for translating these therapies into safe and effective clinical trials.

Main Methods:

  • Comprehensive review of existing literature on pluripotent stem cells in cardiac regeneration.
  • Analysis of challenges including cell delivery, immune tolerance, and proarrhythmic effects.
  • Discussion of drug-mediated interventions and suitable pathological conditions.

Main Results:

  • Current stem cell therapies for heart failure have demonstrated limited clinical efficacy.
  • Significant challenges exist in optimizing cell delivery, ensuring immune tolerance of allogeneic cells, and mitigating proarrhythmic risks.
  • Drug-mediated interventions may enhance cell grafting, and specific pathological conditions could benefit from this approach.

Conclusions:

  • Pluripotent stem cells present a promising avenue for cardiac regeneration, but clinical translation requires overcoming substantial hurdles.
  • Addressing cell delivery systems, immune responses, and safety concerns is crucial for therapeutic success.
  • Established guidelines for cell types and delivery methods are essential for advancing pluripotent stem cell-based cardiac therapies into clinical practice.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.6K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K